Karolinska Institutet
Stockholm, 171 76, Sweden
NCT Number: NCT06299475
To increase sexual and reproductive health and rights through the improvement of contraceptive counseling and easy access to service and, thus, women's use of effective contraceptives after purchase of an emergency contraceptive pill (ECP).
This study is active but is not currently recruiting participants.
15 year and older
Female
Interventional
Not applicable
Stockholm, 171 76, Sweden
This pragmatic cluster randomised cross-over controlled trial aims to determine whether the composite intervention of online contraceptive counseling at the time of a pharmacy provision of emergency contraceptive pill (ECP), plus an invitation to a sexual and reproductive health clinic, will result in increased use of subsequent effective contraception (hormonal or intrauterine) compared with standard care.
The study will be conducted at approximately 30 pharmacies in the Stockholm Region. Clients who will buy an ECP (without prescription) at one of these pharmacies will be invited by posters and pharmacy personnel to participate in the study. By scanning a quick response (QR) code they will receive more information about the study. Eligible women who choose to participate in the study and give their consent will be allocated to intervention or control group depending on the visited pharmacy's allocation.
Participants at the intervention pharmacies will receive an intervention package with online structured contraceptive counseling followed by an online invitation to a clinic for contraceptive provision. While participants at the control pharmacies will purchase the ECP without any further guidance. The order in which the pharmacies will provide the intervention or control will be randomly assigned at a ratio 1:1 by an independent statistician. The recruitment will halter for an intervening period of at least two weeks when the pharmacies switch to the new group depending on their first allocation (cross-over).
An online baseline questionnaire and follow-up questionnaires will be collected at 1 and 12 months following the ECP provision for participants both from intervention and control pharmacies.
The randomized controlled trial will be conducted together with a process evaluation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Online counseling - An educational video including contraceptive models, four key questions and an effectiveness chart (the LOWE intervention material).
Invitation to a clinic - access by weblinks to a regional or national website
Time frame: at 1 month follow-up from the pharmacy visit
Participant´s self-reported use in a digital questionnaire of regular effective contraception (hormonal or intrauterine)
Time frame: within 12 months follow-up
Contraceptive use, including long-acting reversible contraception (LARC) (self-reported use in a digital questionnaire)
Time frame: within 12 months follow-up
Pregnancy and abortion (self-reported use in a digital questionnaire or scrutinized medical record, if lost to follow-up)
Time frame: At 1 month follow-up from the pharmacy visit
Participants' satisfaction with the intervention package (self-reported use in a digital questionnaire) Assessed as: very satisfied, satisfied, neither nor, dissatisfied, very dissatisfied
Time frame: within 12 months follow-up
Contraceptive use, pregnancy, abortion and satisfaction in vulnerable groups such as youths and migrants, compared to non-migrants and older participants (self-reported use in a digital questionnaire or scrutinized medical record, if lost to follow-up)
Time frame: within 12 months follow-up
How context affects the implementation and outcomes among participants and pharmacy personnel (individual interviews)
Karolinska Institutet
Other
Structured Online Contraceptive Counseling at Emergency Contraception Pharmacy Provision - A Cluster Randomized Crossover Trial - (The LOWEC Trial)
Acronym: LOWEC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial DetailsNCT02146950
Contraception
Berlin, Germany
View Trial DetailsNCT05174884
Contraception
Santo Domingo, DN, Dominican Republic
View Trial DetailsNCT07437495
Contraception
Reims, France
View Trial Details